Pterygium: A common presentation with cancerous masquerade conditions

Website intended for a NZ health professional readership

+Practice

In print

EYE HEALTH

Pterygium: A common presentation with cancerous masquerade conditions

3 February 2021

By William Shew and Mo Ziaei

Wednesday 3 February 2021, 12:10 AM

Typical pterygium of the left medial conjunctiva [Image: Supplied]

This article, by William Shew and Mo Ziaei, will help guide you through examination and treatment of pterygium, otherwise known as surfer’s eye

Key points, Pterygia have a strong association with ultraviolet light exposure – the Coroneo effect results in nasal pterygium development. Topical lubricants a, Pract Green w Pale Yellow

Surgery

References

Bradley JC, Yang W, Bradley RH, et al. The science of pterygia. Br J Ophthalmol 2010;94(7):815–20.
Mann I, Potter D. Geographic ophthalmology: A preliminary study of the Maoris of New Zealand. Am J Ophthalmol 1969;67(3):358–69.
Panchapakesan J, Hourihan F, Mitchell P. Prevalence of pterygium and pinguecula: the Blue Mountains Eye Study. Aust N Z J Ophthalmol 1998;26, Supp.1:2–5.
Coroneo M. Ultraviolet radiation and the anterior eye. Eye Contact Lens 2011;37(4):214–24.

How to Treat

+How to treat

Pharmacist prescribers Linda Bryant and Leanne Te Karu discuss positive polypharmacy for heart failure. Current evidence shows the intensive implementation of four medications offers the greatest benefit to most patients with heart failure, with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality

Wednesday 29 January 2025, 12:45 AM